Details for New Drug Application (NDA): 021079
✉ Email this page to a colleague
The generic ingredient in ALAMAST is pemirolast potassium. Additional details are available on the pemirolast potassium profile page.
Summary for 021079
Tradename: | ALAMAST |
Applicant: | Santen |
Ingredient: | pemirolast potassium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.1% | ||||
Approval Date: | Sep 24, 1999 | TE: | RLD: | No |
Expired US Patents for NDA 021079
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Santen | ALAMAST | pemirolast potassium | SOLUTION/DROPS;OPHTHALMIC | 021079-001 | Sep 24, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription